G

Guangdong Hec Technology Holding Co Ltd
SSE:600673

Watchlist Manager
Guangdong Hec Technology Holding Co Ltd
SSE:600673
Watchlist
Price: 32.65 CNY -2.83% Market Closed
Market Cap: ¥98.3B

Guangdong Hec Technology Holding Co Ltd
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Guangdong Hec Technology Holding Co Ltd
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
G
Guangdong Hec Technology Holding Co Ltd
SSE:600673
EPS (Diluted)
¥0
CAGR 3-Years
-41%
CAGR 5-Years
-8%
CAGR 10-Years
8%
C
China Hongqiao Group Ltd
HKEX:1378
EPS (Diluted)
¥2
CAGR 3-Years
36%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Aluminum Corporation of China Ltd
SSE:601600
EPS (Diluted)
¥0
CAGR 3-Years
46%
CAGR 5-Years
90%
CAGR 10-Years
54%
Shandong Hongchuang Aluminum Industry Holding Co Ltd
SZSE:002379
EPS (Diluted)
¥0
CAGR 3-Years
-157%
CAGR 5-Years
-11%
CAGR 10-Years
6%
Yunnan Aluminium Co Ltd
SZSE:000807
EPS (Diluted)
¥1
CAGR 3-Years
10%
CAGR 5-Years
43%
CAGR 10-Years
56%
Tianshan Aluminum Group Co Ltd
SZSE:002532
EPS (Diluted)
¥1
CAGR 3-Years
23%
CAGR 5-Years
16%
CAGR 10-Years
16%
No Stocks Found

Guangdong Hec Technology Holding Co Ltd
Glance View

Market Cap
98.3B CNY
Industry
Metals & Mining

Nestled in the vibrant economic landscape of China, Guangdong Hec Technology Holding Co Ltd operates with the intricacies of a well-oiled machine in the health sector. The company, with its focal point in pharmaceuticals, has been a significant player in the development, manufacturing, and sale of a variety of medicinal products. Its portfolio spans across anti-infectives, digestive medications, and cardiovascular treatments, amassing a reputation for innovation and quality. The company’s commitment to research and development is palpable, as it consistently invests in state-of-the-art laboratories and collaborations with leading scientific minds. This approach not only fuels its pipeline of groundbreaking therapies but also ensures a steady stream of products ready for market. The company's revenue engine hums efficiently through a strategic blend of domestic and international market penetration. By leveraging an extensive distribution network, Guangdong Hec Technology ensures its products reach both regional pharmacies and global pharmaceutical markets. Through meticulous marketing strategies and strategic partnerships, the company has adeptly navigated the complex waters of regulatory compliance and competitive pricing landscapes. Its financial fortitude is further bolstered by a judicious mix of pharmaceutical exports and local sales, highlighting its dual focus on global expansion and domestic consolidation. In this dance of science and commerce, Guangdong Hec Technology continues to solidify its stature, harnessing both innovation and keen business acumen to thrive in the ever-evolving pharmaceutical industry.

Intrinsic Value
15.02 CNY
Overvaluation 54%
Intrinsic Value
Price ¥32.65
G

See Also

What is Guangdong Hec Technology Holding Co Ltd's EPS (Diluted)?
EPS (Diluted)
0.1 CNY

Based on the financial report for Dec 31, 2025, Guangdong Hec Technology Holding Co Ltd's EPS (Diluted) amounts to 0.1 CNY.

What is Guangdong Hec Technology Holding Co Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
8%

Over the last year, the EPS (Diluted) growth was -31%. The average annual EPS (Diluted) growth rates for Guangdong Hec Technology Holding Co Ltd have been -41% over the past three years , -8% over the past five years , and 8% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett